ID    AVR/I/SSAP45
ET    Clinical
PN    Lipopeptide 5
PL    6 [Note: any special compound, if present in sequence, is not considered in length]
SR    Not available
SO    Synthetic peptide
TX    Not available
VL    Experimentally validated
XX
TO    VRSA (NARSA VRS 1) (clinical isolate from the University of Queensland Centre for Clinical Research (UQCCR))
IC    MIC = 0.1 microM
TH    Lipopeptides 5 did not exhibit cytotoxic activity at concentrations up to 15 microM against the tested mammalian cell lines (HEK293 and HepG2) and did not induce significant hemolytic effects even at high concentrations of 100 microM.
XR    PubMed: 27048775
XR    RCSB PDB/PDBsum/PDBe/PDBj/PDBe-KB/MMDB: Not available 
XR    UniProt: Not available
XR    DrugBank: Not available
XX
SQ    SEQUENCE  
      Cyclo(-D-L eu-D-Tyr-D -Leu-D-Phe -D-Pro-D-V al-) 
//

